The FreeMind Group is proud to support the upcoming Trans-Pacific Health Science Dialogue!

Where: Boston, MA

When: September 28-29, 2016

 

Big Players Are Making Big Bets on Biopharma in Asia

  • Chinese investors representing more than $5.5B are looking for Trans-Pacific investments
  • Pfizer is investing $150M in a biologics plant in China
  • BMS expects Opdivo sales in Japan to exceed $1B
  • The Hangzhou Economic Development Area is investing $350M in a global biotech center

Can You Afford to Sit on the Sidelines?

The time to think about establishing, expanding or accelerating an Asian strategy is now. With a lineup of top Asia experts, the Trans-Pacific Health Sciences Dialogue will provide you with a solid grasp of Asian biopharma opportunities and today’s best strategies for market entry and growth. This two-day event provides critical insights you will not find at any other meeting.

 

EARLY REGISRATION ENDS SOON >>> SAVE $300!

For complete details and to register go to:

www.TransPacificHSD.com

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *